Accera Secures $18,397,296 New Financing Round

  • Feed Type
  • Date
    7/30/2012
  • Company Name
    Accera
  • Mailing Address
    380 Interlocken Crescent Broomfield, CO 80021
  • Company Description
    Accera is a private biotechnology company engaged in the discovery and development of innovative therapeutic treatments for neurodegenerative diseases.
  • Website
    http://www.accerapharma.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $18,397,296
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed